Juan C Ivancevich MD @Aller_MD Twitter profile

Last Seen Profiles

@bragazka

@Ujang0168

@0xPhantomDefi

@cutepiuye

@11moonicrisLi

@botas_leon

@xyz_wakasa_zeno

@rizkiadrian

@Babiwyd

@sixbocas

@valleygirlfeet

@RubiRose87659

@christina_99663

@m0zu_yu

@Spectral_Labs

@HonkerHonky

@PhoongLawCorp

@Xelothqh

@Kyon_anime_lov

@Nelsons002

@MichaelFor58193

@MLosAngeles2028

@penyukastw21

@danyelle27476

@CalissaSil99842

@Sykosan

@playplusr

@HarjantoBe36450

@_noytc

@OpinadorProfes4

@RandyDAmico_MD

@jhsdthrow

@WinonaFootball

@SamuelC90143

@Emobeyx1

@TaylanWolf

Juan C Ivancevich MD

@Aller_MD

2 months

#EURneffy (adrenaline nasal spray) approved in the EU as the First and Only Needle-Free Emergency Treatment of Allergic Reactions ( #anaphylaxis ).

0

23

63

Juan C Ivancevich MD

@Aller_MD

2 years

The #FDA has approved #tezepelumab - ekko for self-administration in a prefilled, single-use pen among patients aged 12 years and older with severe #asthma .

0

17

50

Juan C Ivancevich MD

@Aller_MD

1 month

The US Food and Drug Administration (FDA) has approved benralizumab (Fasenra) for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome.

0

15

41

Juan C Ivancevich MD

@Aller_MD

11 months

#Epinephrine , originally used as a treatment for #asthma , has now become a crucial medication for severe allergic reactions. Discover how this versatile drug has evolved over time. #MedicalAdvances #AllergicReactions

6

10

36

Juan C Ivancevich MD

@Aller_MD

3 years

“IMAGES IN CLINICAL MEDICINE: Ectopic Tooth in the Nose”

6

18

34

Juan C Ivancevich MD

@Aller_MD

3 years

Biologic Therapies for Severe Asthma: Have biologic agents for severe asthma been compared to each other in head-to head trials? | NEJM

0

14

32

Juan C Ivancevich MD

@Aller_MD

3 months

Why #fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review. Open Access.

0

11

30

Juan C Ivancevich MD

@Aller_MD

6 years

“Grandfather of allergy, Dr William Frankland, aged 106, on inventing the pollen count, working with Alexander Fleming and spending 70 years in the NHS”

0

15

30

Juan C Ivancevich MD

@Aller_MD

3 years

#Allergen #Immunotherapy for #asthma prevention: a systematic review and meta‐analysis of randomised and non‐randomised controlled studies

0

17

29

Juan C Ivancevich MD

@Aller_MD

3 years

Covid-19: New allergic reactions to hair dye reported. Hairdressers in parts of the UK are reporting clients having new allergic reactions, like rashes and burns, to hair dye after contracting coronavirus.

Covid-19: New allergic reactions to hair dye reported

Scientists at Imperial College London are now researching a link between Covid-19 and new allergies.

www.bbc.com

5

11

26

Juan C Ivancevich MD

@Aller_MD

10 months

Dupilumab could become the first approved biologic for COPD, as it has shown positive results in two phase III trials. This treatment not only reduces exacerbations but also improves lung function. #COPD #Dupilumab

0

15

25

Juan C Ivancevich MD

@Aller_MD

2 years

Aquestive's #Sublingual #Emergency #Epinephrine Compares Favorably to #EpiPen ® in EPIPHAST II Trial

2

11

25

Juan C Ivancevich MD

@Aller_MD

4 years

Why and How Vaccines Work? Excellent review @CellCellPress by @VirusesImmunity and @SaadOmer3 . Includes #COVID ー19 developments. @YaleMed [🔓𝗢𝗣𝗘𝗡 𝗔𝗖𝗖𝗘𝗦𝗦]

Why and How Vaccines Work

Vaccines save millions of lives from infectious diseases caused by viruses and bacteria. As the world awaits safe and effective COVID-19 vaccines, we celebrate the progresses made and highlight...

www.cell.com

0

15

26

Juan C Ivancevich MD

@Aller_MD

4 years

Allergic rhinitis. Nature reviews disease primers

0

14

24

Juan C Ivancevich MD

@Aller_MD

3 years

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR...

BACKGROUND Severe COVID-19 pneumonia results from a hyperinflammatory immune response (cytokine storm, CS), characterized by GM-CSF mediated activation and trafficking of myeloid cells, leading to...

www.medrxiv.org

1

7

23

Juan C Ivancevich MD

@Aller_MD

3 years

Long-term real-world effectiveness of #allergy #immunotherapy in patients with #allergic #rhinitis and #asthma : Results from the REACT study, a retrospective cohort study.

0

11

21

Juan C Ivancevich MD

@Aller_MD

3 years

“Anti-immunoglobulin E (IgE) and anti-interleukin-5 (IL-5) therapies showed similar efficacy in controlling #asthma symptoms, but none were associated with significant improvements in lung function.”

0

8

20

Juan C Ivancevich MD

@Aller_MD

3 years

Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy? This review presents an updated overview of Allergen-Specific Immunotherapy with a special focus on Allergic Rhinitis.

1

11

20

Juan C Ivancevich MD

@Aller_MD

1 year

Efficacy of #Sublingual #Immunotherapy in #Allergic #Rhinitis Patients with #Asthma : A Systematic Review and Meta-Analysis.

0

7

20

Juan C Ivancevich MD

@Aller_MD

3 years

“IMAGES IN CLINICAL MEDICINE: Eosinophilic Granulomatosis with Polyangiitis”

1

9

20

Juan C Ivancevich MD

@Aller_MD

3 years

Top story: @annasalacunill : 'The last day of @EAACI_JM @EAACI_HQ congress #EAACI2021 talking about the “Planetary health in 2021”!! Thanks Dra.Annesi-Maesano for emphasixing the importance of avoiding plastic and to sh… , see more

0

10

19

Juan C Ivancevich MD

@Aller_MD

3 years

Predicting the course of #asthma from childhood until early adulthood: lung function, allergic comorbidity and polysensitization in childhood predict the course of asthma. Open Access

0

10

19

Juan C Ivancevich MD

@Aller_MD

4 years

“Differentiation of #COVID ‐19 signs and symptoms from allergic rhinitis and common cold‐ An ARIA‐EAACI‐GA2LENconsensus”

0

11

19

Juan C Ivancevich MD

@Aller_MD

5 years

Electron microscopy allows scientists to understand the molecular trigger of allergic reactions

An international research team has been able to describe the overall structure of the antibody type IgE, which is the key molecule in allergic diseases. This is a scientific breakthrough which...

medicalxpress.com

0

13

19

Juan C Ivancevich MD

@Aller_MD

3 years

Melatonin exacerbates #asthma . This sleep hormone that is sometimes prescribed to treat insomnia, exasperates the constriction of the bronchus.

Melatonin exacerbates asthma

Asthma sufferers generally find their condition gets worse at night. Now, a research group may understand why. Melatonin, a sleep hormone that is sometimes prescribed to treat insomnia, exasperates...

medicalxpress.com

0

8

19

Juan C Ivancevich MD

@Aller_MD

2 years

Are blood cytokines reliable biomarkers of allergic disease diagnosis and treatment responses?

0

8

17

Juan C Ivancevich MD

@Aller_MD

6 years

Top story: @GTropper : ' #EAACI2018 Don’t hesitate to contribute and share #aller … , see more

1

11

18

Juan C Ivancevich MD

@Aller_MD

3 years

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased...

The LIVE-AIR phase 3 clinical trial is associated with early treatment of hyperinflammatory response with the humanized monoclonal antibody lenzilumab in COVID-19 patients with decreased oxygen...

www.news-medical.net

0

6

16

Juan C Ivancevich MD

@Aller_MD

4 months

iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease Control. Open Access.

0

10

18

Juan C Ivancevich MD

@Aller_MD

3 years

Tezspire (tezepelumab) approved in the US for severe #asthma , First and only biologic to consistently and significantly reduce exacerbations in a broad population of severe asthma patients with no phenotype or biomarker limitations

1

10

17

Juan C Ivancevich MD

@Aller_MD

6 years

Top story: @VijayPatho : 'Proud to be a Pathologist. #pathologyday #pathologyday2018 #pathology International Pathology Day 2018. @BinXu16 @kriyer68 @DrAhmedKalebi @JMGardnerMD @DrGeeONE @TheKarenPinto @DraEosina @smlun … , see more

0

11

15

Juan C Ivancevich MD

@Aller_MD

8 months

Revised guidelines for diagnosing and treating allergic bronchopulmonary aspergillosis/mycoses have been released by the ISHAM-ABPA working group. Stay updated with the latest recommendations! #ISHAM #ABPA .

0

11

18

Juan C Ivancevich MD

@Aller_MD

11 months

FDA has approved the first oral device for treating severe sleep apnea, offering an alternative to CPAP and surgical neurostimulation implants. #SleepApneaTreatment #FDAApproval

0

7

17

Juan C Ivancevich MD

@Aller_MD

3 years

Top story: @allergyuptodate : '𝗟𝗮𝘁𝗲𝘀𝘁 𝗶𝗺𝗽𝗮𝗰𝘁 𝗳𝗮𝗰𝘁𝗼𝗿 𝗳𝗼𝗿 𝗔𝗹𝗹𝗲𝗿𝗴𝘆 𝗝𝗼𝘂𝗿𝗻𝗮𝗹𝘀 - 𝗧𝗼𝗽 𝟭𝟱. @clarivate @webofscience #allergy #journals #impact_factor ' , see more

1

13

17

Juan C Ivancevich MD

@Aller_MD

4 years

Top story: @alvarezperea : ' #AirPollution is affecting many aspects of our life, including development and control of #allergy and #asthma . World-renowned Prof Holgate will address this topic in #EAACI2020 digital congre… , see more

0

15

17

Juan C Ivancevich MD

@Aller_MD

7 years

“A PHARMACIST IS being praised for saving a teenager who went into anaphylactic shock on Dublin’s O’Connell Street after eating a peanut brownie by accident”

0

13

16

Juan C Ivancevich MD

@Aller_MD

9 years

Anaphylaxis to pneumococcal vaccine; CRM(197): Novel cause of vaccine #allergy

Anaphylaxis to pneumococcal vaccine; CRM(197): Novel cause of vaccine allergy

Click on the article title to read more.

onlinelibrary.wiley.com

0

7

17

Juan C Ivancevich MD

@Aller_MD

6 years

Electronic cigarette use ("vaping") is associated with wheezing in adults, according to a new study published in the journal Tobacco Control.

New study links electronic cigarettes and wheezing in adults

Electronic cigarette use ("vaping") is associated with wheezing in adults, according to a new study published in the journal Tobacco Control. People who vaped were nearly twice as likely to experie...

medicalxpress.com

0

15

17

Juan C Ivancevich MD

@Aller_MD

10 months

The FDA has given high priority to omalizumab for the treatment of food allergies. This is great news for those who suffer from this condition. #FoodAllergyTreatment #FDAApproval

0

8

14

Juan C Ivancevich MD

@Aller_MD

2 years

#Anticentromere antibodies (ACAs) can serve as a diagnostic serologic marker for #Sj ögren syndrome, and patients with ACA-positivity should be examined for Sjögren syndrome.

1

11

15

Juan C Ivancevich MD

@Aller_MD

6 years

“Epinephrine Nasal Spray for #Anaphylaxis Shows Promise as Potential Alternative to Auto-Injector”

1

12

16

Juan C Ivancevich MD

@Aller_MD

1 year

Clinical standards for diagnosis, treatment and prevention of #post - #COVID -19 #lung #disease . Open Access pdf.

0

7

16

Juan C Ivancevich MD

@Aller_MD

7 years

A better understanding of how treatment changes affect asthma inflammatory phenotypes and airway neutrophils may help guide #asthma treatment strategies.

0

11

15

Juan C Ivancevich MD

@Aller_MD

3 years

Severe #asthma as the initial clinical manifestation of #IgG4 -related disease: a retrospective clinical study

0

7

16

Juan C Ivancevich MD

@Aller_MD

4 years

Top story: @FlorinDanPopesc : ' @DrShamji : Our world is everchanging, & with the advent of new technologies in medicine: omics, big data, mHealth and the development of #ArtificialInteligence among others, #eaaci2020 cong… , see more

0

12

16

Juan C Ivancevich MD

@Aller_MD

4 months

#Prenatal #Factors in the Development of #Allergic #Diseases . This study aims to highlight the mechanisms that induce allergic reactions, how they progress, and which prenatal factors influence their development.

0

9

16

Juan C Ivancevich MD

@Aller_MD

3 years

Metabolomic study links inhaled cortical steroid treatment for #asthma to adrenal suppression

1

8

16

Juan C Ivancevich MD

@Aller_MD

3 years

“Too high, too low”: the complexities of using thresholds in isolation to inform precautionary allergen (“may contain”) labels

0

8

16

Juan C Ivancevich MD

@Aller_MD

1 year

#Alpha -1 #antitrypsin #deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with #asthma #exacerbations . Open Access.

0

8

16

Juan C Ivancevich MD

@Aller_MD

3 months

$FDA approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as #anaphylaxis . The first needle-free alternative to shots like EpiPen.

0

9

16

Juan C Ivancevich MD

@Aller_MD

3 years

Top story: @Aller_MD : '“Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19”… , see more

0

7

15

Juan C Ivancevich MD

@Aller_MD

3 years

#COVID -19, not vaccination, presents biggest blood clot risks: study by University of Oxford

0

9

16

Juan C Ivancevich MD

@Aller_MD

6 years

The nasal microbiome in #asthma : Nasal microbiome composition differs in subjects with exacerbated asthma, nonexacerbated asthma, and healthy controls.

0

9

15

Juan C Ivancevich MD

@Aller_MD

4 years

FDA Approves Dupixent® (dupilumab) Pre-Filled Pen for Atopic Dermatitis - Eczema

0

8

15

Juan C Ivancevich MD

@Aller_MD

4 years

Top story: @alvarezperea : '"How to use #SocialMedia in your professional practice: the clinician perspective". So glad to share an interactive workshop with @FlorinDanPopesc in #EAACI2020 ' , see more

0

6

14

Juan C Ivancevich MD

@Aller_MD

1 year

#Dupilumab -induced #eosinophilia in patients with diffuse type 2 #chronic #rhinosinusitis . Open Access.

0

8

15

Juan C Ivancevich MD

@Aller_MD

4 months

Since #IL -5-neutralizing monoclonal antibodies are currently available for clinical use, this review revisit the role of IL-5 in #asthma pathogenesis and airway remodelling, in addition to exploring its role as a target for #biological treatments.

0

8

14

Juan C Ivancevich MD

@Aller_MD

4 years

“Trelegy Ellipta Approved for #Asthma Maintenance Treatment”

0

8

15

Juan C Ivancevich MD

@Aller_MD

4 years

Oral Antiviral Stops SARS-CoV-2 in its Tracks: A single pill of the investigational drug molnupiravir taken twice a day for 5 days eliminated SARS-CoV-2 from the nasopharynx of 49 participants.

0

10

15

Juan C Ivancevich MD

@Aller_MD

4 years

Top story: Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests | University of Oxford , see more

1

12

14

Juan C Ivancevich MD

@Aller_MD

6 years

Top story: @ParasiteGal : ' @DrAhmedKalebi @kriyer68 @pembeoltulu @Missle @EOWalong @luishcruzc @DrGeeONE @edusqo @SkinPathology @Dermpathl @DermwizGuy @VijayPatho @Chucktowndoc @TheKarenPinto @smlungpathguy @JMGardnerMD … , see more

0

3

14

Juan C Ivancevich MD

@Aller_MD

8 months

Subcutaneous immunotherapy (SCIT) may be a valuable adjunct for specific individuals with eosinophilic esophagitis (EoE) who have comorbid allergic rhinitis, according to researchers from the U. of North Carolina (UNC) School of Medicine. #AAAAI2024

0

7

13

Juan C Ivancevich MD

@Aller_MD

5 years

A new study from Washington University School of Medicine in St. Louis supports evidence that children with mild asthma can effectively manage the condition by using their two inhalers—one a steroid and the other a bronchodilator—when symptoms occur.

Children with mild asthma can use inhalers as needed

A new study from Washington University School of Medicine in St. Louis supports evidence that children with mild asthma can effectively manage the condition by using their two inhalers—one a steroid...

medicalxpress.com

2

12

13

Juan C Ivancevich MD

@Aller_MD

1 year

#Basophils in #pruritic skin #diseases . Since basophils and neurons share many receptors and channels, bidirectional interaction mechanisms, which drive the sensation of itch, are highlighted in this #review . Open Access.

0

11

14

Juan C Ivancevich MD

@Aller_MD

9 months

New research shows that combining dupilumab with antihistamines is more effective than using antihistamines alone for treating chronic spontaneous urticaria (CSU). Find out more about this breakthrough treatment here: #CSU #treatment

0

6

13

Juan C Ivancevich MD

@Aller_MD

2 months

Allergy: Vol 79, No 9. This issue is dedicated to Marcus #Maurer in recognition of his groundbreaking contributions to the fields of #dermatology and #allergy .

0

7

14

Juan C Ivancevich MD

@Aller_MD

6 months

Glenmark Pharma is set to introduce its nasal spray Ryaltris in the EU market. Stay tuned for this exciting launch! #GlenmarkPharma #Ryaltris

2

6

14

Juan C Ivancevich MD

@Aller_MD

7 years

Anaphylaxis in Children

0

11

14

Juan C Ivancevich MD

@Aller_MD

3 years

Open Access: Biological treatment in allergic disease

0

9

14

Juan C Ivancevich MD

@Aller_MD

6 years

Study identifies why some colds cause #asthma attacks in children

Study identifies why some colds cause asthma attacks in children

Upper respiratory infections remain one of the most common triggers of asthma attacks in children, but not every cold leads to a dangerous worsening of symptoms, even among children with severe...

medicalxpress.com

0

13

14

Juan C Ivancevich MD

@Aller_MD

3 months

First International Position Paper on #mHealth apps in allergen immunotherapy launched by #ARIA and #EAACI .

0

5

13

Juan C Ivancevich MD

@Aller_MD

3 years

“FDA has approved Opzelura (ruxolitinib) cream for the short-term and noncontinuous chronic treatment of mild to moderate atopic dermatitis in nonimmunocompromised patients 12 years of age and older whose disease is not adequately controlled.”

0

8

14

Juan C Ivancevich MD

@Aller_MD

3 years

What's new in GINA 2021? Helen Reddel, GINA Scientific Committee Chair, discussed what is new in GINA2021 and some of its key highlights.

0

13

14

Juan C Ivancevich MD

@Aller_MD

6 years

Researchers at the University of Alabama at Birmingham have shown -; for the first time -; that established lung fibrosis can be reversed using metformin.

0

11

14

Juan C Ivancevich MD

@Aller_MD

4 years

The EAACI “Global Atlas of #Asthma ” 2021 has just published today. It has been written by an international group of 216 opinion leaders in asthma and includes 109 chapters, 202 illustrations and 93 tables. Read the Global Atlas here:

0

10

13

Juan C Ivancevich MD

@Aller_MD

4 months

Eosinophil-associated diseases: the Allergist's and Clinical Immunologist's perspective

0

12

14

Juan C Ivancevich MD

@Aller_MD

7 years

NICE releases the latest #asthma management standards

NICE releases the latest asthma management standards

In 2016 in England and Wales alone, a shocking 1,237 people died from an asthma attack2.

www.news-medical.net

0

16

13

Juan C Ivancevich MD

@Aller_MD

4 years

“Treatment with antihistamines oxatamide, fexofenadine, and ebastine were associated with significant hair regrowth in patients with alopecia areata (AA)”

0

7

14

Juan C Ivancevich MD

@Aller_MD

2 years

Top story: @mar_guilarte : ' @ramcat61 @annasalacunill @t_dordal @Gus_JMMolina @Pgalvan_blasco @pauvazrev @vickycardona @lidiafarrarons @Laiafy @lluismarques1 @drago54Miquel @m_remains @dra_alergia @gperdomog @allergista … , see more

0

9

14

Juan C Ivancevich MD

@Aller_MD

1 year

Eggs, legumes including soya and peanuts, almonds and cashew nuts are now being introduced earlier in infant diets following revised advice on the introduction of certain foods. There has been no change in the rate of #food #allergies or eczema in infants.

1

9

14

Juan C Ivancevich MD

@Aller_MD

2 years

Top story: @ShellyGray100 : 'Common theme today is the detrimental effect of highly processed foods on the gut barrier and inflammation #eaaciasn22 ' , see more

0

10

14

Juan C Ivancevich MD

@Aller_MD

1 year

"Maximizing the Effectiveness of In Vitro Tests for Drug Allergy Diagnosis: Clinical Insights . A clinical viewpoint enhances the potential of in vitro tests in identifying drug allergies. #DrugAllergy #ClinicalInsights "

0

9

12

Juan C Ivancevich MD

@Aller_MD

2 years

Top story: @pai_eaaci : 'Editor's choice. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children or pediatric inflammatory multisystem syndrome: EAACI Position Pape… , see more

0

8

13

Juan C Ivancevich MD

@Aller_MD

1 year

Oral immunotherapy, a potential solution for food allergies in young children, is currently supported by evidence and underlying mechanisms. Discover more about this curative treatment. #foodallergies #immunotherapy

0

6

13

Juan C Ivancevich MD

@Aller_MD

2 months

#Asthma and #COPD are different diseases with differing underlying inflammatory patterns, but some patients have a mixed picture, as these common diseases may coexist. Peter Barnes...

0

12

Juan C Ivancevich MD

@Aller_MD

8 months

#Nasal powder formulations of #epinephrine are effective and show superior stability to EpiPens, according to a study presented at the annual meeting of the #AAAAI24

AAAAI: Nasal delivery of epinephrine safe, effective for anaphylaxis

Nasal powder formulations of epinephrine are effective and show superior stability to EpiPens, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma &...

medicalxpress.com

0

10

12

Juan C Ivancevich MD

@Aller_MD

3 years

Food allergy in children with asthma and its correlation with level of #asthma control

0

9

12

Juan C Ivancevich MD

@Aller_MD

5 years

“Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement”

0

11

12

Juan C Ivancevich MD

@Aller_MD

3 years

NSAID-exacerbated respiratory disease: Older age, family history of asthma or allergic rhinitis, cumulative exposure to tobacco smoke, secondhand smoke, and occupational exposures increased odds of N-ERD. N-ERD was associated with significant morbidity.

1

10

13

Juan C Ivancevich MD

@Aller_MD

4 months

The Use of #Azelastine / #Fluticasone in the Management of #Allergic #Rhinitis in Asia: A Review; published data on the efficacy and safety of its prolonged use in adults and children have validated that effective treatment of AR.

0

5

12

Juan C Ivancevich MD

@Aller_MD

6 years

Adolescents with hay fever have higher rates of anxiety and depression, lower resistance to stress

0

11

12

Juan C Ivancevich MD

@Aller_MD

4 years

Top story: @FlorinDanPopesc : 'Follow #eaaci2020 #ArtificialIntelligence #MachineLearning @DrShamji @efknol @EAACI_HQ ' , see more

0

13

Juan C Ivancevich MD

@Aller_MD

9 months

The airway neuro-immune axis is a promising target for treating allergic airway diseases. Check out this link for more information: . #allergies #airwaydiseases

0

10

12

Juan C Ivancevich MD

@Aller_MD

3 years

Top story: @ProfGRoberts : ' #EAACI2021 : Honoured to be awarded a Fellowship of the European Academy of Allergy & Clinical Immunology with Prof M Akdis, Bousquet & Durham. Everything I have done has only been possible wit… , see more

0

7

13

Juan C Ivancevich MD

@Aller_MD

7 years

How tattoos are maintained by macrophages could be key to improving their removal

Researchers in France have discovered that, though a tattoo may be forever, the skin cells that carry the tattoo pigment are not. Instead, the researchers say, the cells can pass on the pigment to...

medicalxpress.com

0

10

13

Juan C Ivancevich MD

@Aller_MD

3 months

Recent findings suggest that #dupilumab , a monoclonal antibody treatment for atopic dermatitis (AD), may significantly reduce the risk of #atopic #march in children.

0

8

12

Juan C Ivancevich MD

@Aller_MD

6 years

Mount Sinai researchers have identified a genetic biomarker of #asthma that can be tested for using a simple nasal brush and basic follow-up data analysis.

0

10

13

Juan C Ivancevich MD

@Aller_MD

6 years

A phase 2 clinical study of universal influenza vaccine begins in USA: The vaccine contains antigenic peptide sequences shared among many different influenza viruses.

Phase 2 clinical study of universal influenza vaccine begins in the United States

A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.

www.news-medical.net

0

10

11

Juan C Ivancevich MD

@Aller_MD

5 years

“Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence”

0

6

12